FSBCX
Price
$18.68
Change
+$0.20 (+1.08%)
Updated
Apr 11 closing price
Net Assets
252.55M
RIRCX
Price
$69.13
Change
+$0.98 (+1.44%)
Updated
Apr 11 closing price
Net Assets
103.34B
Ad is loading...

FSBCX vs RIRCX

Header iconFSBCX vs RIRCX Comparison
Open Charts FSBCX vs RIRCXBanner chart's image
Federated Hermes Global Allocation C
Price$18.68
Change+$0.20 (+1.08%)
VolumeN/A
Net Assets252.55M
American Funds Capital Income Bldr R3
Price$69.13
Change+$0.98 (+1.44%)
VolumeN/A
Net Assets103.34B
FSBCX vs RIRCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSBCX vs. RIRCX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSBCX is a Buy and RIRCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRCX has more cash in the bank: 103B vs. FSBCX (253M). RIRCX pays higher dividends than FSBCX: RIRCX (2.84) vs FSBCX (1.35). FSBCX was incepted earlier than RIRCX: FSBCX (32 years) vs RIRCX (23 years). FSBCX (2.20) is less costly to investors than RIRCX (0.91). RIRCX has a lower initial minimum investment than FSBCX: RIRCX (250) vs FSBCX (1500). RIRCX annual gain was more profitable for investors over the last year : 6.31 vs. FSBCX (-0.01). RIRCX return over 5 years is better than : 39.76 vs. FSBCX (13.41).
FSBCXRIRCXFSBCX / RIRCX
Total Expense Ratio1.950.91214%
Annual Report Gross Expense Ratio2.200.91242%
Fund Existence32 years23 years-
Gain YTD-4.5610.750-608%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets253M103B0%
Annual Yield % from dividends1.352.8448%
Returns for 1 year-0.016.31-0%
Returns for 3 years2.809.1131%
Returns for 5 years13.4139.7634%
Returns for 10 years6.9829.7823%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STKS2.960.11
+3.86%
ONE Group Hospitality (The)
WLY42.491.02
+2.46%
John Wiley & Sons
CACI412.699.27
+2.30%
Caci International CLA
SRI3.800.01
+0.26%
Stoneridge
HEPA0.42-0.01
-2.11%
Hepion Pharmaceuticals Inc